Enantioselective analysis of antimalarial drugs and their metabolites

Current Pharmaceutical Analysis

Volumn 6, Issue 1, 2010, Pages 15-29

  Santos Magalhães, Igor R ^a   Bonato, Pierina S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimalarial drugs; Biological matrices; Enantioselective analysis; Sample preparation

Indexed keywords

ANTIMALARIAL AGENT; BENFLUMETOL; CHLOROQUINE; DEBUTYLHALOFANTRINE; DEETHYLCHLOROQUINE; DEETHYLHYDROXYCHLOROQUINE; DRUG METABOLITE; ENPIROLINE; FENOZAN B 07; HALOFANTRINE; HYDROXYCHLOROQUINE; MEFLOQUINE; MEPACRINE; PRIMAQUINE; QUININE; TAFENOQUINE; UNCLASSIFIED DRUG;

CAPILLARY ELECTROPHORESIS; ENANTIOSELECTIVITY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID PHASE MICROEXTRACTION; PRIORITY JOURNAL; REVIEW; SOLID PHASE MICROEXTRACTION;

ANIMALIA;

EID: 77950288155     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341210790780186     Document Type: Review

References (170)

1. Burke, D.; Henderson, D.J. Chirality: a blueprint for the future. Br. J. Anaesth., 2002, 88, 563-576.
2. Davies, N.M.; Teng, X.W. Importance of chirality in drug therapy and pharmacy practice: implications for psychiatry. Adv. Pharm., 2003, 1, 242-252.
3. Williams, M.L.; Wainer, I.W. Role of chiral chromatography in therapeutic drug monitoring and in clinical and forensic toxicology. Ther. Drug. Monit., 2002, 24, 290-296.
4. Soudijn, W.; Van Wijngaarden, I.; Ijzerman, A.P. Stereoselectivity of drug-receptor interactions. IDrugs, 2003, 6, 43-56.
5. Nguyen, L.A.; He, H.; Pham-Huy, C. Chiral drugs. An overview. Int. J. Biomed. Sci., 2006, 2, 85-100.
6. Brocks, D.R. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharm. Drug Dispos., 2006, 27, 387-406.
7. Hutt, A.J. Chirality and pharmacokinetics: an area of neglected dimensionality? Drug Metab. Drug Inter., 2007, 22, 79-112.
8. Lu, H. Stereoselectivity in drug metabolism. Expert Opin. Drug Metab. Toxicol., 2007, 3, 149-158.
9. Tucker, G.T. Chiral switches. Lancet, 2000, 355, 1085-1087.
10. Santoro, M.I.R.M.; Singh, A.K. Development and regulation of chiral drugs substances: an overview on worldwide pharmaceutical guidelines. Braz. J. Pharm. Sci., 2001, 37, 259-268.
11. Agranat, I.; Caner, H.; Caldwell, J. Putting chirality to work: the strategy of chiral switches. Nat. Rev. Drug. Discov., 2002, 1, 753-768.
12. Guerin, P.J.; Olliaro, P.; Nosten, F.; Druilhe, P.; Laxminarayan, R.; Binka, F.; Kilama, W.L.; Ford, N.; White, N.J. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect. Dis., 2002, 2, 564-573.
13. Sachs, J.; Malaney, P. The economic and social burden of malaria. Nature, 2002, 415, 680-685.
14. Franco-Paredes, C.; Santos-Preciado, J.I. Problem pathogens: prevention of malaria in travellers. Lancet Infect. Dis., 2006, 6, 139-149.
15. Greenwood, B.M.; Bojang, K.; Whitty, C.J.M.; Targett, G.A.T. Malaria. Lancet, 2005, 365, 1487-1498.
16. Winstanley, P.A.; Ward, S.A.; Snow, R.W. Clinical status and implications of antimalarial drug resistance. Microbes Infect., 2002, 4, 157-164.
17. Kesselheim, A.S. Drug development for neglected diseases - the trouble with FDA review vouchers. N. Engl. J. Med., 2008, 359, 1981-1983.
18. Ridley, R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature, 2002, 415, 686-693.
19. Robert, A.; Benoit-Vical, F.; Dechy-Cabaret, O.; Meunier, B. From classical antimalarial drugs to new compounds based on the mechanism of action of artemisinin. Pure Appl. Chem., 2001, 73, 1173-1188.
20. Egan, T.J. Quinoline antimalarials. Expert Opin. Ther. Pat., 2001, 11, 185-209.
21. Schlitzer, M. Antimalarial drugs - what is in use and what is in the pipeline. Arch. Pharm. Chem. Life Sci., 2008, 341, 149-163.
22. Rosenthal, P.J. Antimalarial drug discovery: old and new approaches. J. Exp. Biol., 2003, 206, 3735-3744.
23. White, N.J. Qinghaosu (artemisinin): the price of success. Science, 2008, 320, 330-334.
24. Ducharme, J.; Farinotti, R. Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin. Pharmacokinet., 1996, 31, 257-274.
25. Basco, L.K.; Gillotin, C.; Gimenez, F.; Farinotti, R.; Le Bras, J. Absence of antimalarial activity or interaction with mefloquine enantiomers in vitro of the main human metabolite of mefloquine. Trans. R. Soc. Trop. Med. Hyg., 1991, 85, 208-209.
26. Fink, E.; Minet, G.; Nickel, P. Chloroquine enantiomers: activity against P. vinckei and binding on DNA. Arzneim. Forsch., 1979, 29, 163-164.
27. Haberkorn, A.; Kraft, H.P.; Blaschke, G. Antimalarial activity in animals of the optical isomers of chloroquine diphosphate. Tropenmed. Parasitol., 1979, 30, 308-312.
28. Fu, S.; Björkman, A.; Wåhlin, B.; Ofori-Adjei, B.; Ericsson, O.; Sjöqvist, F. In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum. Br. J. Clin. Pharmacol., 1986, 22, 93-96.
29. Scaria, P.V.; Craig, J.C.; Shafer, R.H. Differential binding of the enantiomers of chloroquine and quinacrine to polynucleotides: implications for stereoselective metabolism. Biopolymers, 1993, 33, 887-895.
30. Basco, L.K.; Gillotin, C.; Gimenez, F.; Farinotti, R.; Le Bras, J. In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br. J. Clin. Pharmacol., 1992, 33, 517-520.
31. Karle, J.M.; Olmeda, R.; Gerena, L.; Milhous, W.K. Plasmodium Falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents. Exp. Parasitol., 1993, 76, 345-351.
32. Basco, L.K.; Gillotin, C.; Gimenez, F.; Farinotti, R.; Le Bras, J. Activity in vitro of the enantiomers of halofantrine. Trans. R. Soc. Trop. Med. Hyg., 1993, 87, 78-79.
33. Basco, L.K.; Peytavin, G.; Gimenez, F.; Genissel, B.; Farinotti, R.; Le Bras, J. In vitro activity of the enantiomers of N-desbutyl derivative of halofantrine. Trop. Med. Parasitol., 1994, 45, 45-46.
34. Wernsdorfer, W.H.; Landgraf, B.; Kilimali, V.A.E.B.; Wernsdorfer, G. Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. Acta Trop., 1998, 70, 9-15.
35. Brossi, A.; Millet, P.; Landau, I.; Bembenek, M.E.; Abell, C.W. Antimalarial activity and inhibition of monoamine oxidases A and B by exo-erythrocytic antimalarials. Optical isomers of primaquine, N-acylated congeners, primaquine metabolites and 5-phenoxy-substituted analogs. FEBS Lett., 1987, 214, 291-294.
36. Webster, R.V.; Craig, J.C.; Shyamala, V.; Kirby, G.C.; Warhursts, D.C. Antimalarial activity of optical isomers of quinacrine dihydrochloride against chloroquine-sensitive and -resistant Plasmodium falciparum in vitro. Biochem. Pharmacol., 1991, 42, S225-S227.
37. Karle, J.M.; Karle, I.L.; Gerena, L.; Milhous, W.K. Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum. Antimicrob. Agents Chemother., 1992, 36, 1538-1544.
38. Carroll, F.I.; Blackwell, J.T. Optical isomers of aryl-2- piperidylmethanol antimalarial agents. Preparation, optical purity, and absolute stereochemistry. J. Med. Chem., 1974, 17, 210-219.
39. Peters, W.; Robinson, B.L.; Mittelholzer, M.L.; Crevoisier, C.; Stürchler, D. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers. Ann. Trop. Med. Parasitol., 1995, 89, 465-468.
40. Schmidt, L.H.; Alexander, S.; Allen, L.; Rasco, J. Comparison of the curative antimalarial activities and toxicities of primaquine and its d and 1 isomers. Antimicro. Agents Chemoter., 1977, 12, 51-60.
41. Nanayakkara, N.P.D.; Ager Jr., A.L.; Bartlett, M.S.; Yardley, V.; Croft, S.L.; Khan, I.A.; McChesney, J.D.; Walker, L.A. Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4- methyl-5-[3,4-dichlorophenoxy] quinoline succinate. Antimicrob. Agents Chemother., 2008, 52, 2130-2137.
42. Donatelli, P.; Marchi, G.; Pacifici, G.M.; Giuliani, L.; Gustafsson, L.L. Stereoselective inhibition by chloroquine of histamine Nmethyltransferase in the human liver and brain. Eur. J. Clin. Pharmacol., 1994, 47, 345-349.
43. Emami, J.; Pasutto, F.M.; Mercer, J.R.; Jamali, F. Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. Life Sci., 1999, 64, 325-335.
44. Ngiam, T.L.; Go, M.L. Stereospecific inhibition of cholinesterases by mefloquine enantiomers. Chem. Pharm. Bull., 1987, 35, 409-412.
45. Go, M.L.; Lee, H.S.; Ngiam, T.L. Pharmacological activity and structure-activity relationship of (+/-)-erythromefloquine and related compounds on the isolated mouse phrenic nerve diaphragm preparation. Biol. Pharm. Bull., 1993, 16, 668-674.
46. Pham, Y.T.; Régina, A.; Farinotti, R.; Couraud, P.O.; Wainer, I.W.; Roux, F.; Gimenez, F. Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochim. Biophys. Acta, 2000, 1524, 212-219.
47. Ryou, C.; Legname, G.; Peretz, D.; Craig, J.C.; Baldwin, M.A.; Prusiner, S.B. Differential inhibition of prion propagation by enantiomers of quinacrine. Lab. Invest., 2003, 83, 837-843.
48. Tagoe, C.N.B.; Ofori-Adjei, D. Effects of chloroquine and its enantiomers on the development of rat embryos in vitro. Teratology, 1995, 52, 137-142.
49. Ofori-Adjei, D.; Ericsson, Ö.; Lindström, B.; Sjöqvist, F. Protein binding of chloroquine enantiomers and desethylchloroquine. Br. J. Clin. Pharmacol., 1986, 22, 356-358.
50. Augustijns, P.; Verbeke, N. Stereoselective pharmacokinetic properties of chloroquine and de-ethylchloroquine in humans. Clin. Pharmacokinet., 1993, 24, 259-269.
51. Gimenez, F.; Gillotin, C.; Basco, L.K.; Bouchaud, O.; Aubry, A.F.; Wainer, I.W.; Le Bras, J.; Farinotti, R. Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients. Eur. J. Clin. Pharmacol., 1994, 46, 561-562.
52. McLachlan, A.J.; Cutler, D J.; Tett, S.E. Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites. Eur. J. Clin. Pharmacol., 1993, 44, 481-484.
53. McLachlan, A.J.; Tett, S.E.; Cutler, D.J.; Day, R.O. Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. Br. J. Clin. Pharmacol., 1993, 36, 78-81.
54. Brocks, D.R.; Skeith, K.J.; Johnston, C.; Emamibafrani, J.; Davis, P.; Russell, A.S.; Jamali, F. Hematologic disposition of hydroxychloroquine enantiomers. J. Clin. Pharmacol., 1994, 34, 1088-1097.
55. McLachlan, A.J.; Tett, S.E.; Cutler, D.J.; Day, R.O. Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate. Chirality, 1994, 6, 360-364.
56. Tett, S.E.; McLachlan, A.J.; Cutler, D.J.; Day, R.O. Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate. Chirality, 1994, 6, 355-359.
57. Ducharme, J.; Fieger, H.; Ducharme, M.P.; Khalil, S.K.W.; Wainer, I.W. Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects. Br. J. Clin. Pharmacol., 1995, 40, 127-133.
58. Martin, C.; Gimenez, F.; Bangchang, K.N.; Karbwang, J.; Wainer, I.W.; Farinotti, R. Whole blood concentrations of mefloquine enantiomers in healthy Thai volunteers. Eur. J. Clin. Pharmacol., 1994, 47, 85-87.
59. Gimenez, F.; Pennie, R.A.; Koren, G.; Crevoisier, C.; Wainer, I.W.; Farinotti, R. Stereoselective pharmacokinetics of mefloquine in healthy caucasians after multiple doses. J. Pharm. Sci., 1994, 83, 824-827.
60. Bourahla, A.; Martin, C.; Gimenez, F.; Singhasivanon, V.; Attanath, P.; Sabchearon, A.; Chongsuphajaisiddhi, T.; Farinotti, R. Stereoselective pharmacokinetics of mefloquine in young children. Eur. J. Clin. Pharmacol., 1996, 50, 241-244.
61. Schlagenhauf, P.; Steffen, R.; Lobel, H.; Johnson, R.; Letz, R.; Tschopp, A.; Vranjes, N.; Bergqvist, Y.; Ericsson, Ö.; Hellgren, U.; Rombo, L.; Mannino, S.; Handschin, J.; Stürchler, D. Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop. Med. Int. Health, 1996, 1, 485-494.
62. Hellgren, U.; Berggren-Palme, I.; Bergqvist, Y.; Jerling, M. Enantioselective pharmacokinetics of mefloquine during long-term intake of the prophylactic dose. Br. J. Clin. Pharmacol., 1996, 44, 119-124.
63. Pham, Y.T.; Nosten, F.; Farinotti, R.; White, N.J.; Gimenez, F. Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int. J. Clin. Pharmacol. Ther., 1999, 37, 58-61.
64. Augustijns, P.; Verbeke, N. Stereoselectivity in the disposition of chloroquine and desethylchloroquine in rabbits. Arzneim. Forsch., 1992, 42, 825-828.
65. Augustijns, P.; Peeters, L.; Croes, K.; Verbeeck, R.K. Stereoselective de-ethylation of chloroquine in rat liver microsomes. Eur. J. Drug Metab. Pharmacokinet., 1999, 24, 105-108.
66. Brocks, D.R.; Toni, J.W. Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons. Biopharm. Drug Dispos., 1999, 20, 165-169.
67. Brocks, D.R. Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug. Biopharm. Drug Dispos., 2000, 21, 365-371.
68. Ducharme, J.; Wainer, I.W.; Parenteau, H.I. ; Rodman, J.H. Stereoselective distribution of hydroxychloroquine in the rabbit following single and multiple oral doses of the racemate and the separate enantiomers. Chirality, 1994, 6, 337-346.
69. Wainer, I.W.; Chen, J.C.; Parenteau, H.; Abdullah, S.; Ducharme, J.; Fieger, H.; Iredale, J. Distribution of the enantiomers of hydroxychloroquine and its metabolites in ocular tissues of the rabbit after oral administration of racemic hydroxychloroquine. Chirality, 1994, 6, 347-354.
70. Wei, Y.; Nygard, G.A.; Ellertson, S.L.; Khalil, S.K.W. Stereoselective disposition of hydroxychloroquine and its metabolites in rats. Chirality, 1995, 7, 598-604.
71. Emami, J.; Pasutto, F.M.; Jamali, F. Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats. Pharm. Res., 1998, 15, 897-903.
72. Koch, M.; Blaschke, G. Separation and metabolism of mefloquine enantiomers. Arch. Pharm., 1990, 323, 749.
73. Baudry, S.; Pham, Y.T.; Baune, B.; Vidrequin, S.; Crevoisier, C.; Gimenez, F.; Farinotti, R. Stereoselective passage of mefloquine through the blood-brain barrier in the rat. J. Pharm. Pharmacol., 1997, 49, 1086-1090.
74. Baker, J.K.; McChesney, J.D. Differential metabolism of the enantiomers of primaquine. J. Pharm. Sci., 1988, 77, 380-382.
75. Brocks, D.R.; Mehvar, R. Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin. Pharmacokinet., 2003, 42, 1359-1382.
76. Gübitz, G.; Schmid, M.G. Chiral separation principles in chromatographic and electromigration techniques. Mol. Biotechnol., 2006, 32, 159-180.
77. Haginaka, J. Pharmaceutical and biomedical applications of enantioseparations using liquid chromatographic techniques. J. Pharm. Biomed. Anal., 2002, 27, 357-372.
78. Gübitz, G.; Schmid, M.G. Chiral separation by chromatographic and electromigration techniques. A review. Biopharm. Drug Dispos., 2001, 22, 291-336.
79. Thompson, R. A practical guide to HPLC enantioseparations for pharmaceutical compounds. J. Liq. Chromatogr. Relat. Technol., 2005, 28, 1215-1231.
80. Zhang, Y.; Wu, D.R.; Wang-Iverson, D.B.; Tymiak, A.A. Enantioselective chromatography in drug discovery. Drug Discov. Today, 2005, 10, 571-577.
81. Zhou, S.; Song, Q.; Tang, Y.; Naidong, W. Critical review of development, validation, and transfer for high-throughput bioanalytical LC-MS/MS methods. Curr. Pharm. Anal., 2005, 1, 3-14.
82. Erny, G.L.; Cifuentes, A. Liquid separation techniques coupled with mass spectrometry for chiral analysis of pharmaceuticals compounds and their metabolites in biological fluids. J. Pharm. Biomed. Anal., 2006, 40, 509-515.
83. Ofori-Adjei, D.; Ericsson, O.; Lindström, B.; Hermansson, J.; Adjepon-Yamoah, K.; Sjöqvist, F. Enantioselective analysis of chloroquine and desethylchloroquine after oral administration of racemic chloroquine. Ther. Drug Monit., 1986, 8, 457-461.
84. Ibrahim, K.E.; Fell, A.F. Separation of chloroquine enantiomers by high-performance liquid chromatography. J. Pharm. Biomed. Anal., 1990, 8, 449-452.
85. 1-acid glycoprotein chiral stationary phase: evidence for a multiple-site chiral recognition mechanism. Chirality, 1992, 4, 30-35.
86. Okamoto, Y.; Hatano, K.; Aburatani, R.; Hatada, K. Tris(4- tbutylphenylcarbamate) s of cellulose and amylose as useful chiral stationary phases for chromatographic optical resolution. Chem. Lett., 1989, 715-718.
87. Safni Ito, N.; Takeuchi, T.; Miwa, T. Separation of enantiomers on anion exchangers modified with heparin in liquid chromatography. J. Chromatogr. A, 1999, 864, 25-30.
88. Desai, M.J.; Armstrong, D.W. Transforming chiral liquid chromatography methodologies into more sensitive liquid chromatography-electrospray ionization mass spectrometry without losing enantioselectivity. J. Chromatogr. A, 2004, 1035, 203-210.
89. A-deoxy)-perphenylcarbamoylated α- and γ- cyclodextrin. Chirality, 2004, 16, 592-597.
90. Magalhães, I.R.S.; Bonato, P.S. Enantioselective determination of chloroquine and its n-dealkylated metabolites in plasma using liquid- phase microextraction and LC-MS. J. Sep. Sci., 2008, 31, 3106-3116.
91. Camilleri, P.; Dyke, C.; Hossner, F. Chiral separation of the optical isomers of the antimalarial drug halofantrine. J. Chromatogr., 1989, 477, 471-473.
92. Gimenez, F.; Aubry, A.F.; Farinotti, R.; Kirkland, K.; Wainer, I.W. The determination of the enantiomers of halofantrine and monodesbutylhalofantrine in plasma and whole blood using sequential achiral/chiral high-performance liquid chromatography. J. Pharm. Biomed. Anal., 1992, 10, 245-250.
93. Kirkland, K.M.; McCombs, D.A. Changes in chiral selectivity with temperature for an ovomucoid protein-based column. J. Chromatogr. A, 1994, 666, 211-219.
94. Terefe, H.; Blaschke, G. Direct determination of the enantiomers of halofantrine and its pharmacologically active metabolite N-desbutylhalofantrine by high-performance liquid chromatography. J. Chromatogr., 1993, 615, 347-351.
95. Gorichon, E.; Martin, C.; Na-Bangchang, K.; Karbwang, J.; Thuillier, A.; Farinotti, R.; Gimenez, F. Chiral chromatographic method to determine the enantiomers of halofantrine and its main chiral desbutyl metabolite in erythrocytes. J. Chromatogr. B, 1998, 712, 259-262.
96. Brocks, D.R.; Dennis, M.J.; Schaefer, W.H. A liquid chromatographic assay for the stereospecific quantitative analysis of halofantrine in human plasma. J. Pharm. Biomed. Anal., 1995, 13, 911-918.
97. Brocks, D.R. A high-performance liquid chromatographic assay for the determination of desbutylhalofantrine enantiomers in rat plasma. J. Pharm. Pharm. Sci., 2001, 4, 24-31.
98. 1-acid glycoprotein stationary phase. J. Chromatogr., 1991, 570, 119-127.
99. Midha, K.K.; Hubbard, J.W.; Rawson, M.J.; McKay, G.; Schwede, R. The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: a drug with a very long half-life. Eur. J. Pharm. Sci., 1996, 4, 283-292.
100. Iredale, J.; Wainer, I.W. Determination of hydroxychloroquine and its major metabolites in plasma using sequential achiral-chiral high-performance liquid chromatography. J. Chromatogr., 1992, 572, 253-258.
101. Fieger, H.; Iredale, J.; Wainer, I.W. Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(-)-hydroxychloroquine ratio. Chirality, 1992, 5, 65-70.
102. Iredale, J.; Fieger, H.; Wainer, I.W. Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine. Semin. Arthritis Rheum., 1993, 23, 74-81.
103. Wei, Y.; Nygard, G.A.; Khalil, S.K.W. A HPLC method for the separation and quantification of the enantiomers of hydroxychloroquine and its three major metabolites. J. Liq. Chromatogr. Relat. Technol., 1994, 17, 3479-3490.
104. Brocks, D.R.; Pasutto, F.M.; Jamali, F. Analytical and semipreparative high-performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers. J. Chromatogr. B, 1992, 581, 83-92.
105. Cardoso, C.D.; Bonato, P.S. Enantioselective analysis of the metabolites of hydroxychloroquine and application to an in vitro metabolic study. J. Pharm. Biomed. Anal., 2005, 37, 703-708.
106. de Oliveira, A.R.M.; Bonato, P.S. Stereoselective determination of hydroxychloroquine and its major metabolites in human urine by solid-phase microextraction and HPLC. J. Sep. Sci., 2007, 30, 2351-2359.
107. Gimenez, F.; Farinotti, R.; Thuillier, A.; Hazebroucq, G.; Wainer, I.W. Determination of the enantiomers of mefloquine in plasma and whole blood using a coupled achiral-chiral high-performance liquid chromatographic system. J. Chromatogr., 1990, 529, 339-346.
108. Gimenez, F.; Dumartin, C.; Wainer, I.W.; Farinotti, R. Improved column-switching liquid chromatographic method for the determination of the enantiomers of mefloquine. J. Chromatogr., 1993, 619, 161-166.
109. Bergqvist, Y.; Al Kabbani, J.; Pettersson, C.; Huynh, N.H. Enantioselective high-performance liquid chromatographic determination of (SR)- and (RS)-mefloquine in plasma using N-benzyloxycarbonyl-glycyl-L-proline as chiral counter ion. J. Chromatogr., 1993, 620, 217-224.
110. Bergqvist, Y.; Doverskog, M.; Al Kabbani, J. High-performance liquid chromatographic determination of (SR)- and (RS)-enantiomers of mefloquine in plasma and capillary blood sampled on paper after derivatization with (-)-l-(9-fluorenyl)ethyl chloroformate. J. Chromatogr. B, 1994, 652, 73-81.
111. Souri, E.; Farsam, H.; Jamali, F. Stereospecific determination of mefloquine in biological fluids by high-performance liquid chromatography. J. Chromatogr. B, 1997, 700, 215-222.
112. Wallén, L.; Ericsson, Ö.; Wikström, I.; Hellgren, U. High-performance liquid chromatographic method for the enantioselective analysis of mefloquine in plasma and urine. J. Chromatogr. B, 1994, 655, 153-157.
113. Magalhães, I.R.S.; Bonato, P.S. Liquid-phase microextraction combined with high-performance liquid chromatography for the enantioselective analysis of mefloquine in plasma samples. J. Pharm. Biomed. Anal., 2008, 46, 929-936.
114. Qiu, Y.; Kitamura, S.; Guillory, J.K. A high-performance liquid chromatographic method for the quantitative enantioselective analysis of mefloquine stereoisomers. Pharm. Res., 1992, 9, 1640-1643.
115. Magalhães, I.R.S.; Bonato, P.S. Two-step liquid-phase microextraction and high-performance liquid chromatography for the simultaneous analysis of the enantiomers of mefloquine and its main metabolite carboxymefloquine in plasma. Anal. Bioanal. Chem., 2009, 393, 1805-1813.
116. Bonato, P.S.; Bortocan, R.; Gaitani, C.M.; Paias, F.O.; Ilha, M.H.; Lima, R.P. Enantiomeric resolution of drugs and metabolites in polysaccharide- and protein-based chiral stationary phases. J. Braz. Chem. Soc., 2002, 13, 190-199.
117. Machida, Y.; Nishi, H.; Nakamura, K.; Nakai, H.; Sato, T. Enantiomer separation of amino compounds by a novel chiral stationary phase derived from crown ether. J. Chromatogr. A, 1998, 805, 85-92.
118. Haque, A.; Stewart, J.T. Chiral separations of selected pharmaceuticals on avidin column. J. Liq. Chromatogry Relat. Technol., 1998, 21, 2675-2687.
119. Karle, J.M.; Olmeda, R.; Freeman, S.G.; Schroeder, A.C. Quantification of the individual enantiomer plasma concentrations of the candidate antimalarial agent N4-[2,6 -dimethoxy-4-methyl-5-[(3-trifluoromethyl)phenoxy]-8-quinolinyl]- l,4-pentanediamine (WR238,605). J. Chromatogr. B, 1995, 670, 251-257.
120. Maraschiello, C.; Vilageliu, J.; Dorronsoro, I.; Martinez, A.; Floriano, F.; Gómez-Acebo, E. Enantioselective LC/MS method for the determination of an antimalarial agent Fenozan B07 in dog plasma. Chirality, 2006, 18, 297-305.
121. Wätzig, H.; Günter, S. Capillary electrophoresis - a high performance analytical separation technique. Clin. Chem. Lab. Med., 2003, 41, 724-738.
122. Kostal, V.; Katzenmeyer, J.; Arriaga, E.A. Capillary electrophoresis in bioanalysis. Anal. Chem., 2008, 80, 4533-4550.
123. Zaugg, S.; Thormann, W. Enantioselective determination of drugs in body fluids by capillary electrophoresis. J. Chromatogr. A, 2000, 875, 27-41.
124. Gübitz, G.; Schmid, M.G. Chiral separation by capillary electromigration techniques. J. Chromatogr. A, 2008, 1204, 140-156.
125. Wistuba, D.; Schurig, V. Enantiomer separation of chiral pharmaceuticals by capillary electrochromatography. J. Chromatogr. A, 2000, 875, 255-276.
126. Geiser, L.; Veuthey, J.L. Nonaqueous capillary electrophoresis in pharmaceutical analysis. Electrophoresis, 2007, 28, 45-57.
127. Du, Y.; Taga, A.; Suzuki, S.; Liu, W.; Honda, S. Colominic acid: a novel chiral selector for capillary electrophoresis of basic drugs. J. Chromatogr. A, 2002, 962, 221-231.
128. Du, Y.; Taga, A.; Suzuki, S.; Liu, W.; Honda, S. Effect of structure modification of chondroitin sulfate C on its enantioselectivity to basic drugs in capillary electrophoresis. J. Chromatogr. A, 2002, 947, 287-299.
129. Gotti, R.; Cavrini, V.; Andrisano, V.; Mascellani, G. Dermatan sulfate as useful chiral selector in capillary electrophoresis. J. Chromatogr. A, 1998, 805, 205-211.
130. Agyei, N.M.; Gahm, K.H.; Stalcup, A.M. Chiral separations using heparin and dextran sulfate in capillary zone electrophoresis. Anal. Chim. Acta, 1995, 307, 185-191.
131. Gotti, R.; Cavrini, V.; Andrisano, V.; Mascellani, G. Semisynthetic chondroitins as chiral buffer additives in capillary electrophoresis. J. Chromatogr. A, 1999, 845, 247-256.
132. Stalcup, A.M.; Agyei, N.M. Heparin: a chiral mobile-phase additive for capillary zone electrophoresis. Anal. Chem., 1994, 66, 3054-3059.
133. Stalcup, A.M.; Gahm, K.H.; Baldueza, M. Chiral separation of chloroquine using heparin as a chiral selector in high-performance liquid chromatography. Anal. Chem., 1996, 68, 2248-2250.
134. Phinney, K.W.; Jinadu, L.A.; Sander, L.C. Chiral selectors from fruit: application of citrus pectins to enantiomer separations in capillary electrophoresis. J. Chromatogr. A, 1999, 857, 285-293.
135. Chankvetadze, B.; Lomsadze, K.; Burjanadze, N.; Breitkreutz, J.; Pintore, G.; Chessa, M.; Bergander, K.; Blaschke, G. Comparative enantioseparations with native β-cyclodextrin, randomly acetylated β-cyclodextrin and heptakis-(2,3-di-O-acetyl)-β-cyclodextrin in capillary electrophoresis. Electrophoresis, 2003, 24, 1083-1091.
136. Dong, Y.; Huang, A.; Sun, Y.; Sun, Z. Chiral separation of chloroquine and pemoline by capillary zone electrophoresis with sulfobutyl ether β-cyclodextrin as buffer additive. Chromatographia, 1998, 48, 310-313.
137. Jin, L.J.; Li, S.F.Y. Comparison of chiral recognition capabilities of cyclodextrins for the separation of basic drugs in capillary zone electrophoresis. J. Chromatogr. B, 1998, 708, 257-266.
138. Yang, G.S.; Chen, D.M.; Yang, Y.; Tang, B.; Gao, J.J.; Aboul-Enein, H.Y.; Koppenhoefer, B. Enantioseparation of some clinically used drugs by capillary electrophoresis using sulfated β-cyclodextrin as a chiral selector. Chromatographia, 2005, 62, 441-445.
139. Taga, A.; Du, Y.; Suzuki, S.; Honda, S. Capillary electrophoretic separation of drug enantiomers in human serum. J. Pharm. Biomed. Anal., 2003, 30, 1587-1593.
140. Müller, D.; Blaschke, G. Enantioselective assay of chloroquine and its main metabolite deethyl chloroquine in human plasma by capillary electrophoresis. J. Chromatogr. Sci., 2000, 38, 435-440.
141. Cardoso, C.D.; Jabor, V.A.P.; Bonato, P.S. Capillary electrophoretic chiral separation of hydroxychloroquine and its metabolites in the microsomal fraction of liver homogenates. Electrophoresis, 2006, 27, 1248-1254.
142. de Oliveira, A.R.M.; Cardoso, C.D.; Bonato, P.S. Stereoselective determination of hydroxychloroquine and its metabolites in human urine by liquid-phase microextraction and CE. Electrophoresis, 2007, 28, 1081-1091.
143. Fanali, S.; Camera, E. Use of cyclodextrins in the capillary electrophoretic separation of erythro- and threo-mefloquine enantiomers. J. Chromatogr. A, 1996, 745, 17-23.
144. Koppenhoefer, B.; Epperlein, U.; Xiaofeng, Z.; Bingcheng, L. Separation of enantiomers of drugs by capillary electrophoresis. Part 4: Hydroxypropyl-gammacyclodextrin as chiral solvating agent. Electrophoresis, 1997, 18, 924-930.
145. Koppenhoefer, B.; Epperlein, U.; Jakob, A.; Wuerthner, S.; Xiaofeng, Z.; Bingcheng, L. Separation of enantiomers of drugs by capillary electrophoresis, part 7: Gammacyclodextrin as chiral solvating agent. Chirality, 1998, 10, 548-554.
146. Koppenhoefer, B.; Epperlein, U.; Schlunk, R.; Zhu, Y.; Bingcheng, L. Separation of enantiomers of drugs by capillary electrophoresis V. Hydroxypropyl-α-cyclodextrin as chiral solvating agent. J. Chromatogr. A, 1998, 793, 153-164.
147. Chankvetadze, B.; Burjanadze, N.; Maynard, D.M.; Bergander, K.; Bergenthal, D.; Blaschke, G. Comparative enantioseparations with native β-cyclodextrin and heptakis-(2-O-methyl-3,6-di-O-sulfo)-β- cyclodextrin in capillary electrophoresis. Electrophoresis, 2002, 23, 3027-3034.
148. Chankvetadze, B.; Burjanadze, N.; Blaschke, G. Enantioseparation of erythro-mefloquine and its analogues in capillary electrophoresis. J. Pharm. Biomed. Anal., 2003, 32, 41-49.
149. Wistuba, D.; Bogdanski, A.; Larsen, K.L.; Schurig, V. δ-Cyclodextrin as novel chiral probe for enantiomeric separation by electromigration methods. Electrophoresis, 2006, 27, 4359-4363.
150. Jiang, Z.; Thorogate, R.; Smith, N.W. Highlighting the role of the hydroxyl position on the alkyl spacer of hydroxypropyl-β-cyclodextrin for enantioseparation in capillary electrophoresis. J. Sep. Sci., 2008, 31, 177-187.
151. Desiderio, C.; Aturki, Z.; Fanali, S. Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds. Electrophoresis, 2001, 22, 535-543.
152. Zarbl, E.; Lämmerhofer, M.; Franco, P.; Petracs, M.; Lindner, W. Development of stereoselective nonaqueous capillary electrophoresis system for the resolution of cationic and amphoteric analytes. Electrophoresis, 2001, 22, 3297-3307.
153. Tobler, E.; Lämmerhofer, M.; Wuggenig, F.; Hammerschmidt, F.; Lindner, W. Low-molecular-weight chiral cation exchangers: novel chiral stationary phases and their application for enantioseparation of chiral bases by nonaqueous capillary electrochromatography. Electrophoresis, 2002, 23, 462-476.
154. Zarbl, E.; Lämmerhofer, M.; Woschek, A.; Hammerschmidt, F.; Parenti, C.; Cannazza, G.; Lindner, W. Strong versus weak chiral cation exchangers: comparative evaluation for enantiomer separation of chiral bases by non-aqueous CEC. Electrophoresis, 2002, 25, 1269-1283.
155. Nishi, H.; Izumoto, S.; Nakamura, K.; Nakai, H.; Sato, T. Dextran and dextrin as chiral selectors in capillary zone electrophoresis. Chromatographia, 1996, 42, 617-630.
156. Nishi, H.; Kuwahara, Y. Enantiomer separation by capillary electrophoresis utilizing carboxymethyl derivatives of polysaccharides as chiral selectors. J. Pharm. Biomed. Anal., 2002, 27, 577-585.
157. Tanaka, Y.; Terabe, S. Partial separation zone technique for the separation of enantiomers by affinity electrokinetic chromatography with proteins as chiral pseudo-stationary phases. J. Chromatogr. A, 1995, 694, 277-284.
158. 1-acid glycoprotein as chiral selector. Chromatographia, 1997, 44, 119-128.
159. Nishi, H.; Nakamura, K.; Nakai, H.; Sato, T. Separation of enantiomers and isomers of amino compounds by capillary electrophoresis and high-performance liquid chromatography utilizing crown ethers. J. Chromatogr. A, 1997, 757, 225-235.
160. Bortocan, R.; Bonato, P.S. Enantioselective analysis of primaquine and its metabolite carboxyprimaquine by capillary electrophoresis. Electrophoresis, 2004, 25, 2848-2853.
161. Nishi, H.; Nakamura, K.; Nakai, H.; Sato, T. Chiral separation of drugs by capillary electrophoresis using β-cyclodextrin polymer. J. Chromatogr. A, 1994, 678, 333-342.
162. Tanaka, Y.; Yanagawa, M.; Terabe, S. Separation of neutral and basic enantiomers by cyclodextrin electrokinetic chromatography using anionic cyclodextrin derivatives as chiral pseudo-stationary phases. J. High Resolut. Chromatogr., 1996, 19, 421-433.
163. Nishi, H.; Kokusenya, Y.; Miyamoto, T.; Sato, T. Chiral separation of drugs using cyclodextrins in capillary zone electrophoresis. J. Chromatogr. A, 1994, 659, 449-457.
164. Elbashir, A.A.; Saad, B.; Ali, A.S.M.; Saleh, M.I. Development of a capillary electrophoresis method for the enantioselective estimation of primaquine in pharmaceutical formulations. J. AOAC Int., 2008, 91, 536-541.
165. Elbashir, A.A.; Saad, B.; Ali, A.S.M.; Saleh, M.I.; Aboul-Enein, H.Y. Enantioselective analysis of primaquine and its impurity quinocide by capillary electrophoresis. Biomed. Chromatogr., 2009, 23, 295-301.
166. Zhang, C.; Zhu, C.; Lin, X.; Gao, F.; Wei, Y. Enantiomeric separation of primaquine, an antimalarial drug, by cyclodextrin-modified micellar electrokinetic capillary chromatography. Anal. Sci., 2002, 18, 595-597.
167. Pedersen-Bjergaard, S.; Rasmussen, K.E. Liquid-phase microextraction with porous hollow fibers, a miniaturized and highly flexible format for liquid-liquid extraction. J. Chromatogr. A, 2008, 1184, 132-142.
168. Lee, J.; Lee, H.K.; Rasmussen, K.E.; Pedersen-Bjergaard, S. Environmental and bioanalytical applications of hollow fiber membrane liquid-phase microextraction: a review. Anal. Chim. Acta, 2008, 624, 253-268.
169. Pragst, F. Application of solid-phase microextraction in analytical toxicology. Anal. Bioanal. Chem., 2007, 388, 1393-1414.
170. Kataoka, H. Recent advances in solid-phase microextraction and related techniques for pharmaceutical and biomedical analysis. Curr. Pharm. Anal., 2005, 1, 65-84.